Evaluation and Management of Skin Lesions in a Patient on Supraphysiologic Prednisone
Immediate Priority: Address Glucocorticoid Over-Replacement
This 78-year-old woman is receiving 40 mg prednisone daily—a dose that is 8-10 times higher than the recommended replacement range for adrenal insufficiency and represents severe iatrogenic glucocorticoid excess, not physiologic replacement therapy. 1, 2
The "random fern-like skin lesions" (likely referring to striae or other glucocorticoid-induced skin changes) are almost certainly manifestations of chronic glucocorticoid toxicity from this supraphysiologic dose. 1
Algorithmic Approach to Management
Step 1: Confirm the Diagnosis of Adrenal Insufficiency
- Review the original diagnostic workup to verify that adrenal insufficiency was properly diagnosed with morning cortisol and ACTH measurements or cosyntropin stimulation testing 1, 2
- If no prior diagnostic confirmation exists, do not attempt testing while the patient remains on prednisone—the exogenous steroid will suppress the HPA axis and yield false results 2, 3
Step 2: Immediately Reduce to Physiologic Replacement Dosing
The correct replacement dose for confirmed adrenal insufficiency is:
- Prednisone 4-5 mg daily (taken as a single morning dose), OR 1
- Hydrocortisone 15-25 mg daily in divided doses (typically 10 mg at 7:00 AM, 5 mg at 12:00 PM, and 2.5-5 mg at 4:00 PM) 1, 4
Prednisolone 4-5 mg daily should only be considered in select patients who experience marked fluctuations in energy or when hydrocortisone is not tolerated. 1
Step 3: Add Mineralocorticoid Replacement if Primary Adrenal Insufficiency
- If the patient has primary adrenal insufficiency (autoimmune, adrenoleukodystrophy, tuberculosis, hemorrhage), add fludrocortisone 50-200 µg daily taken in the morning 1, 5
- Advise unrestricted salt and salty food intake, avoiding potassium-containing salt substitutes 1, 5
- Secondary adrenal insufficiency does not require mineralocorticoid replacement 5, 6
Step 4: Evaluate the Skin Lesions After Dose Correction
Signs of glucocorticoid over-replacement include:
- Weight gain (particularly truncal and facial) 1, 4
- Peripheral edema 1, 4
- Insomnia 1, 4
- Skin changes: striae, easy bruising, thin fragile skin, poor wound healing 1
After reducing to physiologic replacement doses, reassess the skin lesions in 2-4 weeks:
- Many glucocorticoid-induced skin changes will improve or stabilize once excess exposure is eliminated 1, 4
- If lesions persist or worsen despite appropriate dosing, consider dermatology referral for biopsy to exclude other etiologies 1
Step 5: Monitor for Signs of Under-Replacement
After dose reduction, watch for symptoms requiring dose adjustment:
- Lethargy, nausea, poor appetite, weight loss, increased pigmentation (primary AI only) indicate under-replacement 1, 2, 4
- Morning nausea can be relieved by taking the first dose earlier and returning to sleep 1, 2
Step 6: Essential Patient Education
All patients with adrenal insufficiency must receive:
- Medical alert bracelet or necklace indicating adrenal insufficiency 1, 2
- Steroid emergency card 1, 2
- Injectable hydrocortisone 100 mg IM kit with self-injection training 1, 2, 6
- Stress-dosing instructions: double or triple the dose during fever, infection, or minor illness 2, 4, 6
- Immediate emergency care instructions: for vomiting, severe illness, or inability to take oral medications 2, 6, 7
Critical Pitfalls to Avoid
Never continue supraphysiologic glucocorticoid doses (>7.5 mg prednisone equivalent) for chronic adrenal insufficiency replacement—this causes iatrogenic Cushing's syndrome with serious complications including osteoporosis, diabetes, cardiovascular disease, and skin fragility. 1, 4, 6
Never abruptly discontinue glucocorticoids in confirmed adrenal insufficiency—this will precipitate life-threatening adrenal crisis. 1, 2, 6
Never delay treatment of suspected adrenal crisis for diagnostic procedures—if the patient develops hypotension, altered mental status, or severe vomiting, give hydrocortisone 100 mg IV immediately plus 0.9% saline infusion at 1 L/hour. 1, 2, 6
Drug Interactions Requiring Dose Adjustment
Medications that increase glucocorticoid requirements:
- Anticonvulsants (phenytoin, carbamazepine, phenobarbital) 1, 4
- Rifampin and other antituberculosis drugs 1, 4
- Topiramate 1
Substances that decrease glucocorticoid requirements (avoid or reduce dose):
For primary adrenal insufficiency, avoid medications that interfere with fludrocortisone:
- Diuretics, acetazolamide, NSAIDs, carbenoxolone 1, 5
- Drospirenone-containing contraceptives may require fludrocortisone dose increase 1, 5
Follow-Up Monitoring
Annual review should include:
- Assessment of weight, blood pressure (supine and standing), and presence of peripheral edema 1, 5
- Serum electrolytes (sodium, potassium) 1
- Screening for new autoimmune disorders (thyroid function, diabetes, celiac disease, pernicious anemia) 2, 6
- Bone mineral density every 3-5 years to assess for glucocorticoid-induced osteoporosis 1